Transforming Pediatric Oncology Research: The Role of Collaboration, Precision Medicine, and Evolving Study Designs

被引：0

作者：

Srinivasan, Shyam ^{[1
]}

机构：

[1] Homi Bhabha Natl Inst, Tata Mem Ctr, Dept Pediat Oncol, Mumbai, Maharashtra, India

来源：

PEDIATRIC BLOOD & CANCER | 2025年 / 72卷 / 03期

关键词：

pediatric oncology; precision medicine; randomized controlled trials; trial designs; HIGH-RISK; TRIALS;

D O I：

10.1002/pbc.31486

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 25 条

[1] Global Equity in Clinical Trials: An ASCO Policy Statement [J].

Al Sukhun, Sana A. ;

Vanderpuye, Verna ;

Taylor, Carolyn ;

Ibraheem, Abiola Falilat ;

Rodriguez, Andres Wiernik ;

Asirwa, Fredrick Chite ;

Francisco, Michael ;

Moushey, Allyn .

JCO GLOBAL ONCOLOGY, 2024, 10

[2]

[Anonymous], 2020, Cancer Clinical Trial Eligibility Criteria: Minimum Age Considerations for Inclusion of Pediatric Patients, Guidance for Industry and IRBs

[3]

[Anonymous], ADAPTIVE DESIGNS CLI

[4]

Berry SM, 2010, CH CRC BIOSTAT SER, P1, DOI 10.1201/EBK1439825488

[5] Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations [J].

Bouffet, Eric ;

Hansford, Jordan R. ;

Garre, Maria Luisa ;

Hara, Junichi ;

Plant-Fox, Ashley ;

Aerts, Isabelle ;

Locatelli, Franco ;

van der Lugt, Jasper ;

Papusha, Ludmila ;

Sahm, Felix ;

Tabori, Uri ;

Cohen, Kenneth J. ;

Packer, Roger J. ;

Witt, Olaf ;

Sandalic, Larissa ;

Bento Pereira da Silva, Ana ;

Russo, Mark ;

Hargrave, Darren R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (12) :1108-1120

[6] New clinical trial design in precision medicine: discovery, development and direction [J].

Duan, Xiao-Peng ;

Qin, Bao-Dong ;

Jiao, Xiao-Dong ;

Liu, Ke ;

Wang, Zhan ;

Zang, Yuan-Sheng .

SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)

[7] Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial [J].

Eckstein, Olive S. ;

Allen, Carl E. ;

Williams, P. Mickey ;

Roy-Chowdhuri, Sinchita ;

Patton, David R. ;

Coffey, Brent ;

Reid, Joel M. ;

Piao, Jin ;

Saguilig, Lauren ;

Alonzo, Todd A. ;

Berg, Stacey L. ;

Ramirez, Nilsa C. ;

Jaju, Alok ;

Mhlanga, Joyce ;

Fox, Elizabeth ;

Hawkins, Douglas S. ;

Mooney, Margaret M. ;

Takebe, Naoko ;

Tricoli, James, V ;

Janeway, Katherine A. ;

Seibel, Nita L. ;

Parsons, D. Williams .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (20) :2235-+

[8] Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group [J].

Gupta, Abha A. ;

Xue, Wei ;

Harrison, Douglas J. ;

Hawkins, Douglas S. ;

Dasgupta, Roshni ;

Wolden, Suzanne ;

Shulkin, Barry ;

Qumseya, Amira ;

Routh, Jonathan C. ;

MacDonald, Tamara ;

Feinberg, Shari ;

Crompton, Brian ;

Rudzinski, Erin R. ;

Arnold, Michael ;

Venkatramani, Raj .

LANCET ONCOLOGY, 2024, 25 (07) :912-921

[9]

Herrera AF, 2023, J CLIN ONCOL, V41

[10] Current Challenges of Asian National Children's Cancer Study Groups on Behalf of Asian Pediatric Hematology and Oncology Group [J].

Li, Chi-kong ;

Kurkure, Purna ;

Arora, Ramandeep Singh ;

Chen, Bow Wen ;

Kirgizov, Kirill ;

Okamoto, Yasuhiro ;

Seksarn, Panya ;

Tang, Yongmin ;

Yoo, Keon Hee ;

Agarwal, Bharat ;

Chan, Godfrey C. F. ;

Dalvi, Rashmi ;

Hori, Hiroki ;

Khan, Muhammad Saghir ;

Yu, Alice ;

Nakagawara, Akira .

JCO GLOBAL ONCOLOGY, 2023, 9

← 1 2 3 →